Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6 Anxiety Disorders 4 Uterine Neoplasms 2 Prostatic Neoplasms 2 Pain 2 Ovarian Neoplasms 2 Vomiting 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain, Procedural 1 Motor Activity 1 Mood Disturbances 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Gynecologic Cancer 1 Fallopian Tube Neoplasms 1 Depression 1 Chronic Disease 1 Cancer Pain 1 Breast Neoplasms 1 Anemia, Sickle Cell 1

Interventions

Morphine 16 Oxycodone 14 Fentanyl 10 Methadone 7 nabiximols 5 Lidocaine 5 Acetaminophen 5 resiniferatoxin 4 Hydromorphone 4 Ethanol 4 Acupuncture Therapy 4 Transcutaneous Electric Nerve Stimulation 3 Buprenorphine 3 Transcranial Direct Current Stimulation 2 Tapentadol 2 Surveys and Questionnaires 2 Standard of Care 2 Sodium Bicarbonate 2 Radiosurgery 2 Radiofrequency Ablation 2 Pharmaceutical Services 2 Naloxone 2 Ketamine 2 Electroacupuncture 2 Dronabinol 2 Control Groups 2 Analgesics, Opioid 2 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2 tanezumab 1 rofecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Pain × Imagery, Psychotherapy × Clear all

NCT04572074 2022-12-05

Virtual Reality for Cancer Pain Management

Medstar Health Research Institute

Phase NA Completed

Cancer Pain, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡